Baseline characteristics and admission laboratory data of hospitalized patients with COVID-19
| Characteristics or laboratory values | Patients with DM (n=111) | Patients without DM (n=158) | P value |
| Age (years) | 59.2 (49.0–71.5) | 56.2 (42.0–67.1) | 0.10 |
| BMI (n*=102, n=139) | 29.5 (25.8–35.1) | 26.2 (22.4–31.8) | <0.001 |
| Race | 0.20 | ||
| White | 18 (16.2) | 42 (26.5) | |
| Black | 11 (9.9) | 16 (10.1) | |
| Latinx | 48 (43.2) | 55 (34.8) | |
| Asian | 25 (22.5) | 26 (16.4) | |
| Other | 9 (8.1) | 19 (12.0) | |
| Male, n (%) | 67 (60.3) | 103 (65.2) | 0.44 |
| HbA1c (n=92, n=47) | 7.4 (6.6–9.3) | 5.8 (5.5–6.0) | <0.001 |
| Type 2 DM | 99 (89.2) | – | |
| Outpatient insulin use | 48 (43.2) | – | |
| Glucose (mg/dL) (n=110, n=150) | 163.5 (112–225) | 108 (99–124) | <0.001 |
| WBC (cells ×109/L) (n=111, n=155) | 6.8 (4.6–8.7) | 6.7 (4.8–9.4) | 0.85 |
| HCO3 (mEq/L) (n=111, n=152) | 23 (21–25) | 24 (21–26) | 0.38 |
| Cr (mg/dL) (n=110, n=152) | 1.1 (0.8–1.6) | 0.9 (0.8–1.2) | 0.04 |
| CRP (mg/L) (n=92, n=127) | 65.2 (32.5–165.1) | 75.3 (31.7–125.9) | 0.54 |
| Anion gap (n=110, n=150) | 11 (9–13) | 10 (9–12) | 0.02 |
| pH (n=92, n=122) | 7.40 (7.35–7.42) | 7.41 (7.36–7.43) | 0.09 |
| COVID-19 treatment with dexamethasone (n=74, n=104) | 32 (43.2) | 31 (29.8) | 0.06 |
Data are displayed as median, IQR, or n (%).
*When n is specified in the left column, not all patients had laboratory value obtained.
BMI, body mass index; Cr, creatinine; CRP, C-reactive protein; DM, diabetes mellitus; HbA1c, hemoglobin A1c; HCO3, bicarbonate; WBC, white blood cell count.